Related Experiment Video
Updated: Jun 7, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Elevated plasma YKL-40 levels and ischemic stroke in the general population
Alisa D Kjaergaard1, Stig E Bojesen, Julia S Johansen
1Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
Insights
Elevated plasma YKL-40 levels significantly increase the risk of ischemic stroke and cerebrovascular disease in the general population. This association remains independent of C-reactive protein (CRP) levels, highlighting YKL-40 as a potential biomarker.
Area of Science:
- Cardiovascular Epidemiology
- Biomarker Discovery
- Vascular Biology
Background:
- YKL-40, a protein produced by macrophages in vessel walls, is implicated in inflammatory processes.
- Elevated C-reactive protein (CRP) is a known indicator of inflammation and cardiovascular risk.
- The role of YKL-40 as a predictor of ischemic cardiovascular disease in the general population requires further investigation.
Purpose of the Study:
- To test the hypothesis that higher plasma YKL-40 levels are associated with an increased risk of ischemic cardiovascular disease.
- To compare the predictive value of YKL-40 with CRP for ischemic events.
- To determine if the association between YKL-40 and ischemic events is independent of CRP and other cardiovascular risk factors.
Main Methods:
- Plasma YKL-40 levels were measured in 8,899 participants from the Copenhagen City Heart Study.
- Participants were followed for up to 18 years for endpoints including ischemic stroke, cerebrovascular disease, myocardial infarction, and ischemic heart disease.
- Hazard ratios were calculated for different percentile categories of plasma YKL-40, adjusting for multiple factors including CRP.
Main Results:
- Elevated plasma YKL-40 levels were significantly associated with an increased risk of ischemic stroke and ischemic cerebrovascular disease.
- A dose-dependent relationship was observed, with the highest YKL-40 percentile category showing a 2.3-fold increased risk for ischemic stroke.
- Doubling plasma YKL-40 was linked to a 20% higher risk of ischemic stroke and a 16% higher risk of ischemic cerebrovascular disease, independent of CRP.
Conclusions:
- Plasma YKL-40 is a significant independent predictor of ischemic stroke and ischemic cerebrovascular disease in the general population.
- YKL-40 offers valuable prognostic information beyond traditional risk factors and CRP.
- Further research into YKL-40's role in atherogenesis and its therapeutic potential is warranted.
Objective:
We hypothesized that elevated plasma YKL-40 levels are associated with increased risk of ischemic cardiovascular disease in the general population. In contrast to C-reactive protein (CRP) produced in the liver in response to inflammation, YKL-40 is produced by lipid-laden macrophages inside the vessel wall.
Methods:
We measured plasma YKL-40 in 8,899 21- to 93-year-old participants of the Copenhagen City Heart Study 1991-1994 examination, and followed them for up to 18 years. Endpoints were ischemic stroke, ischemic cerebrovascular disease, myocardial infarction, and ischemic heart disease. Hazard ratios were calculated for plasma YKL-40 levels in 10-year age percentile categories of 34 to 66%, 67 to 90%, and 91 to 100% versus 0 to 33%.
Results:
Multifactorially and CRP-adjusted hazard ratios for ischemic stroke were 1.2 (95% confidence interval, 0.9-1.6) for 33 to 66%, 1.8 (1.3-2.4) for 67 to 90%, and 2.3 (1.5-3.3) for 91 to 100% versus the 0 to 33% percentile category (p-trend < 0.001). Corresponding hazard ratios for ischemic cerebrovascular disease were 1.2 (0.9-1.5), 1.6 (1.2-2.0), and 2.2 (1.6-3.2) (p-trend < 0.001). Hazard ratios for myocardial infarction were not significant, whereas corresponding hazard ratios for ischemic heart disease were 1.0 (0.8-1.2), 1.2 (1.0-1.5), and 1.3 (1.0-1.6) (p-trend = 0.01). Stratifying for CRP or other risk factors gave similar results. A doubling in plasma YKL-40 was associated with multifactorially and CRP-adjusted increased risk of 20% (95% confidence interval, 11%-30%) for ischemic stroke, 16% (8%-24%) for ischemic cerebrovascular disease, 3% (-5%-11%) for myocardial infarction, and 7% (1%-12%) for ischemic heart disease.
Interpretation:
In the general population, elevated plasma YKL-40 levels are associated with increased risk of ischemic stroke and ischemic cerebrovascular disease, independent of plasma CRP levels.
Related Concept Videos
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Transient Ischemic Attack l: Introduction
